How can the risk that orphan drugs present to budgets be managed better?
Ciaran
C
O'Neill
D002017:Budgets; D017850:Economics, Pharmaceutical; D017048:Health Care Costs; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics; D009965:Orphan Drug Production / Q000191:economics*; D035583:Rare Diseases / Q000188:drug therapy* / Q000191:economics; D012051:Reimbursement Mechanisms / Q000191:economics